Patent ID: 9320793
Filing Date: 2016-04-26
CPC Classification: A61K,A61P,C07K

Claim Text:
1. A method for treating a disease associated with or resulting from the accumulation of soluble oligomer amyloid beta 1-42 comprising administering to a subject in need thereof a dose of less than 10 mg/kg body weight of (a) an antibody, or antibody fragment thereof, which has an affinity for amyloid beta 1-42 oligomers compared to amyloid beta 1-40 monomers in a competitive binding assay of at least 500:1 and has: (b) an antibody, or antibody fragment thereof, which has an affinity for amyloid beta 1-42 oligomers compared to amyloid beta 1-40 monomers in a competitive binding assay of at least 500:1 and has: so that the disease associated with or resulting from the accumulation of soluble oligomer amyloid beta 1-42 is treated.